What is it? Why is it important?

Off-site monitoring (e.g. or remote monitoring), relates to monitoring activities where the monitor contacts the study site through e-mail, telephone, or conference calls. The aim is to:

  • Assess the progress of the study site (e.g. current number of included or planned study participants)
  • Track / address monitoring issues (e.g. resolution of queries, study staff fluctuations, status of data entry)
  • Prepare the site for an on-site visit (e.g. set a date, inform about planned monitoring activities, staff support by the site)

 

The monitor checks documents (e.g. copies) provided by the site, and/or discusses relevant study procedures (e.g. informed consent procedures).

 

Due to data protection laws, documents provided by the site must not contain any participant identifiers (e.g. name, DOB, address). Regulators do not normally allow the remote checking of patient files (e.g. participant medical records) as the complete de-identification of documents is considered too challenging.

What do I need to do?

As a monitor, define off-site monitoring tasks such as to remotely:

  • Review copies of study documents (e.g. site delegation log, drug accountability logs, IMP/IMD storage temperature logs)
  • Discuss study procedures (e.g. participant consenting procedures, the exclusive use of EC/RA (e.g. Swissmedic) approved documents, ongoing adherence to safety reporting requirements)

 

Regarding study monitoring services, off-site monitoring activities should be included in the study budget. Likewise other monitoring activities (e.g. on-site- and central data monitoring), off-site monitoring checks should be included in the study monitoring plan.

More

Certain aspects can only be monitored through on-site monitoring, such as:

  • ICF checks needed to confirm that all recruited participants did date and sign the document
  • Process checks needed to confirm the correct handling and monitoring of investigational product (e.g. IMP/IMD preparation, storage, ongoing inventory, implementation of an emergency plan in the event of freezer breakdown)
  • Patient file checks needed to verify that:
    • Respective entries made in the eCRF are correct and correspond to original entries in the patient file (e.g. called Source Data Verification (SDV))
    • Study participant inclusion and exclusion are complied with when including participants for the study (e.g. study eligibility)

Where can I get help?

Your local CTU can support you with experienced staff regarding this topic

 

**References**

ICH GCP E6(R2) – see in particular guidelines

  • 5.18 Monitoring activities

ISO 14155 Medical Device – see in particular section (access liable to costs)

  • 9.2.4 Monitoring
Abbreviations
  • CTU – Clinical Trials Unit
  • DOB – Date of Birth
  • EC/RA – Ethics Committee / Regulatory Authorities
  • eCRF – electronic Case Report Form
  • IC – Informed Consent
  • ICH GCP – International Council for Harmonisation Good Clinical Practice
  • IMP/IMD – Investigational Medicinal Product/Medical Device
  • ISO – International Organisation for Standardisation
  • SDV – Source Data Verification
Development ↦ Monitoring ↦ Montoring Strategy ↦ Off-Site Monitoring
Study
Basic

Provides some background knowledge and basic definitions

Basic Monitoring
Basic Drug or Device
Concept

Starts with a study idea

Ends after having assessed and evaluated study feasibility

Concept Statistic Methodology
Concept Drug or Device
Development

Starts with confidence that the study is feasible

Ends after having received ethics and regulatory approval

Development Drug or Device
Set-Up

Starts with ethics and regulatory approval

Ends after successful study initiation

Set-Up Ethics and Laws
Set-Up Statistic Methodology
Set-Up Quality and Risk
Set-Up Drug or Device
Conduct

Starts with participant recruitment

Ends after the last participant has completed the last study visit

Conduct Statistic Methodology
Conduct Drug or Device
Completion

Starts with last study visit completed

Ends after study publication and archiving

Completion Drug or Device
Current Path (click to copy): Development ↦ Monitoring ↦ Montoring Strategy ↦ Off-Site Monitoring

Please note: the Easy-GCS tool is currently under construction.